Physician profile
Steve Lee
NPI 1699971465
$56,503.08
in general payments reported to CMS, 2019-2025
80 companies · $7,307 in 2025
The $7,307 reported for 2025 was more than what 93% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,033 · 2021: $2,928 · 2022: $21K · 2023: $5,469 · 2024: $5,951 · 2025: $7,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,878 · Consulting Fee: $5,000 · Travel and Lodging: $4,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,877.93 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $4,848.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Interventional Pain Technologies INC. | $14,500.00 | 2022 | |
| Nevro Corp. | $5,566.70 | 2019-2024 | Senza |
| Boston Scientific Corporation | $5,372.11 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $3,767.93 | 2021-2025 | Liberty Si, Ha Minuteman G3-R |
| Surgentec | $3,229.12 | 2023-2024 | Tilink, Ion, Ion Facet Screw System |
| Camber Spine Technologies LLC | $3,000.00 | 2022 | |
| Abbott Laboratories | $2,205.32 | 2019-2025 | Eterna, Proclaim, Octrode |
| Saluda Medical Americas, INC. | $2,030.22 | 2023-2025 | Evoke Scs, Evoke |
| Medtronic, INC. | $1,597.14 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Collegium Pharmaceutical, INC. | $1,353.29 | 2019-2025 | Belbuca, Xtampza |
| Biodelivery Sciences International, INC. | $1,250.37 | 2019-2021 | |
| Genesys Orthopedics Systems, L.L.C. | $1,134.10 | 2023 | Sacroiliac Joint Fusion System |
| Relievant Medsystems, INC. | $1,028.62 | 2020-2023 | Intracept |
| Stryker Corporation | $941.95 | 2020-2025 | Mild Device Kit |
| Titan Pharmaceuticals, INC. | $779.71 | 2019-2020 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $629.19 | 2021-2024 | Nalu Neurostimulation System |
| Forte Bio-Pharma LLC | $477.42 | 2020-2024 | Prolate, Nalocet |
| Globus Medical, INC. | $463.49 | 2025 | Senza, Vyrsa V1 |
| Pacira Pharmaceuticals Incorporated | $422.23 | 2021-2023 | Iovera |
| Horizon Therapeutics Plc | $356.07 | 2019-2022 | |
| Mml US, INC. | $354.71 | 2024-2025 | Reactiv8 |
| Virtus Pharmaceuticals LLC | $344.57 | 2021-2025 | Levorphanol Tartrate |
| Arbor Pharmaceuticals, INC. | $339.02 | 2019-2022 | |
| Ibsa Pharma INC. | $336.69 | 2020-2025 | Tirosint, Licart, Licart |
| Amgen INC. | $315.47 | 2021-2024 | Uplizna, Aimovig |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.34 | 2019-2025 | Relistor |
| Medtronic USA, INC. | $256.59 | 2019-2020 | |
| Abbvie INC. | $215.64 | 2021-2025 | |
| Stratus Medical, LLC | $214.43 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $206.11 | 2022 | |
| Sentynl Therapeutics, INC. | $199.06 | 2019-2020 | |
| Vertiflex, INC. | $181.43 | 2019 | |
| Almatica Pharma LLC | $154.93 | 2021-2023 | Gralise |
| Biotronik Nro, INC. | $143.28 | 2025 | Prospera |
| Spr Therapeutics, INC | $142.30 | 2019-2025 | Sprint Pns System |
| Painteq LLC | $139.52 | 2021-2023 | Painteq |
| Tersera Therapeutics LLC | $137.44 | 2019-2023 | Prialt |
| Indivior INC. | $137.38 | 2019-2025 | Sublocade |
| Nutech Spine, INC. | $130.36 | 2022 | |
| Stimwave Technologies Incorporated | $128.50 | 2021-2022 | |
| Zyla Life Sciences, INC. | $126.04 | 2019-2020 | |
| Genzyme Corporation | $124.83 | 2019 | |
| Grt US Holding, INC. | $123.97 | 2020-2022 | |
| Curonix LLC | $108.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mdd US Operations, LLC | $106.45 | 2019 | |
| Pfizer INC. | $105.15 | 2019-2022 | |
| Redhill Biopharma INC. | $93.23 | 2020-2021 | |
| Bioventus LLC | $90.75 | 2023-2025 | Stimrouter Implantable Kit, Durolane, Durolane |
| Vertex Pharmaceuticals Incorporated | $90.65 | 2025 | |
| Azurity Pharmaceuticals, INC. | $86.95 | 2023-2025 | Horizant, Horizant |
| Scilex Pharmaceuticals INC. | $83.31 | 2019-2024 | Ztlido |
| Daiichi Sankyo INC. | $81.79 | 2019 | |
| Allergan, INC. | $81.07 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $75.25 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $68.46 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.62 | 2020 | |
| Alkermes, INC. | $52.22 | 2019-2021 | |
| Orexo US, INC. | $48.83 | 2019-2022 | |
| Vertos Medical, INC. | $35.32 | 2019 | |
| Pacira Therapeutics, INC. | $25.98 | 2019-2020 | |
| Merz North America, INC. | $25.90 | 2023 | Xeomin |
| Upsher-Smith Laboratories LLC | $24.87 | 2022 | |
| Fidia Pharma USA INC. | $24.64 | 2024 | Hymovis, Hyalgan, Triluron |
| Assertio Therapeutics, INC. | $23.19 | 2019 | |
| Baudax Bio INC. | $22.85 | 2022 | |
| Lundbeck LLC | $22.38 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.33 | 2023 | Epidiolex |
| Convatec INC. | $20.31 | 2024 | |
| Neurocrine Biosciences, INC. | $19.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.76 | 2021 | |
| Impel Pharmaceuticals INC. | $19.26 | 2023 | Trudhesa |
| Alfasigma USA, INC. | $19.15 | 2022 | |
| Braeburn INC. | $18.87 | 2023 | Brixadi |
| Teva Pharmaceuticals USA, INC. | $18.61 | 2021 | |
| Valinor Pharma, LLC | $16.13 | 2025 | Movantik |
| Flowonix Medical Incorporated | $15.78 | 2020 | |
| Grifols USA, LLC | $14.02 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.67 | 2023 | Seglentis |
| Shionogi INC | $12.38 | 2019 | |
| Metacel Pharmaceuticals LLC | $11.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.